HALO : Halozyme Therapeutics stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)
The 2 Wall Street analysts offering Halozyme Therapeutics stock forecast in the last 6 months have average price target of $55.0 with a high forecast of $60.0 and a low forecast of $50.0. The average Halozyme Therapeutics stock forecast represents a 28.59% increase from the last price of $42.77. From AI system, total return is 2022.2% from 1610 forecasts. For Halozyme Therapeutics stock forecast 2021, 8 predictions are offered for each month of 2021 with average Halozyme Therapeutics stock forecast of $39.84, a high forecast of $42.02, and a low forecast of $37.86. The average Halozyme Therapeutics stock forecast 2021 represents a -6.86% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2022, 12 predictions are offered for each month of 2022 with average Halozyme Therapeutics stock forecast of $35.81, a high forecast of $37.3, and a low forecast of $35.22. The average Halozyme Therapeutics stock forecast 2022 represents a -16.27% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2025, 12 predictions are offered for each month of 2025 with average Halozyme Therapeutics stock forecast of $41.11, a high forecast of $41.59, and a low forecast of $40.68. The average Halozyme Therapeutics stock forecast 2025 represents a -3.88% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Halozyme Therapeutics stock forecast of $41.96, a high forecast of $42.18, and a low forecast of $41.62. The average Halozyme Therapeutics stock forecast 2026 represents a -1.89% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2030, 12 predictions are offered for each month of 2030 with average Halozyme Therapeutics stock forecast of $38.11, a high forecast of $39.81, and a low forecast of $36.6. The average Halozyme Therapeutics stock forecast 2030 represents a -10.89% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2031 (10 year), 4 predictions are offered for each month of 2031 with average Halozyme Therapeutics stock forecast of $35.73, a high forecast of $36.3, and a low forecast of $35.08. The average Halozyme Therapeutics stock forecast 2031 represents a -16.45% decrease from the last price of $42.77. Please, see more forecasts below.
Statistics
HALO : Halozyme Therapeutics stock forecast Wall Street by analysts
The average Halozyme Therapeutics stock forecast from last 6 month is $55.0, and this show a 53.85% increase in average from the prior price target of the each prediction. Also, this average forecast of $55.0 represents a 73.23% increase from the past average forecast of $31.75, 6 months ago from 8 wall street analysts.
Halozyme Therapeutics stock forecast for upcoming days

Long term Halozyme Therapeutics(HALO) stock forecast for 2021, 2022 (1 year) - 2025, 2026 (5 year) - 2030, and 2031 (10 year)
Forecast for May. 2021 is $42.02 , for Apr. 2022 is $35.86 , for Apr. 2025 is $40.83 , for Apr. 2026 is $41.80 , for Apr. 2030 is $38.77 , and for Apr. 2031 is $35.08.

Financial Data for Halozyme Therapeutics stock
Frequently Asked Questions about Halozyme Therapeutics stock forecast
Is Halozyme Therapeutics a good long term stock?
From Halozyme Therapeutics stock forecast 2021, Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for May. 2021 is $42.0173049733591 From Halozyme Therapeutics stock forecast 2022, Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for Apr. 2022 is $35.8611539438308 From Halozyme Therapeutics stock forecast 2025, Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for Apr. 2025 is $40.8342112793204 From Halozyme Therapeutics stock forecast 2026, Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for Apr. 2026 is $41.8015857846114 From Halozyme Therapeutics stock forecast 2030, Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for Apr. 2030 is $38.7672159641793 From Halozyme Therapeutics stock forecast 2031, Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for Apr. 2031 is $35.080255920107
Is Halozyme Therapeutics stock overvalued?
Halozyme Therapeutics (HALO) stock is expected to go DOWN . Therefore, AI Pickup would say that Halozyme Therapeutics (HALO) stock is overvalued.
Will Halozyme Therapeutics stock price go up?
No. The Halozyme Therapeutics stock price forecast for Apr. 2022 is $35.8611539438308
Is Halozyme Therapeutics stock a good buy now?
Since closing price on 2021-04-09 is $42.77 and forecast for Apr. 2022 is $35.86, Halozyme Therapeutics stock is not a good 1 year investment.